Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III or Stage IV Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01715077
What this trial is testing

Study of Ipilimumab in the Immune System

Who this might be right for
Previously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma
University Health Network, Toronto 4
Testing effectiveness (Phase 2)Looking for participantsNCT05428007
What this trial is testing

Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
MelanomaUnresectable Melanoma
NYU Langone Health 105
Early research (Phase 1)Study completedNCT00006022
What this trial is testing

Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
Virginia Commonwealth University 17
Testing effectiveness (Phase 2)Study completedNCT01894672
What this trial is testing

BRAF Inhibitor, LGX818, Utilizing a Pulsatile Schedule in Patients With Stage IV or Unresectable Stage III Melanoma Characterized by a BRAFV600 Mutation

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 7
Not applicableLooking for participantsNCT04045691
What this trial is testing

Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment

Who this might be right for
Melanoma Stage IVMelanoma Stage III
Pierre Fabre Pharma GmbH 750
Early research (Phase 1)Ended earlyNCT03727789
What this trial is testing

CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma

Who this might be right for
Advanced Cutaneous Melanoma of the ExtremityAdvanced Sarcoma of the ExtremityClinical Stage III Cutaneous Melanoma AJCC v8+10 more
Roswell Park Cancer Institute 7
Early research (Phase 1)Study completedNCT02935790
What this trial is testing

Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab

Who this might be right for
Malignant Melanoma
Celgene 1
Early research (Phase 1)Study completedNCT00091143
What this trial is testing

Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Providence Cancer Center, Earle A. Chiles Research Institute 20
Early research (Phase 1)Study completedNCT00453050
What this trial is testing

Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin

Who this might be right for
Melanoma (Skin)Metastatic Cancer
University of Oklahoma 11
Early research (Phase 1)Study completedNCT00034554
What this trial is testing

Study of gp75 Vaccine in Patients With Stage III and IV Melanoma

Who this might be right for
Malignant Melanoma
Eli Lilly and Company 31
Large-scale testing (Phase 3)Looking for participantsNCT06624644
What this trial is testing

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Who this might be right for
Melanoma (Skin Cancer)Melanoma Stage IIIB-IVCutaneous Melanoma+1 more
Linnaeus Therapeutics, Inc. 135
Testing effectiveness (Phase 2)UnknownNCT00010309
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Genzyme, a Sanofi Company
Testing effectiveness (Phase 2)Ended earlyNCT03241927
What this trial is testing

Pembrolizumab Effects on NK Cell Exhaustion in Melanoma (Merck NK-IIT)

Who this might be right for
Melanoma
Nina Bhardwaj 1
Early research (Phase 1)Study completedNCT00217542
What this trial is testing

Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaRecurrent Renal Cell CancerStage III Melanoma+2 more
National Cancer Institute (NCI) 42
Very early researchStudy completedNCT03655756
What this trial is testing

PDNA Intralesional Cancer Vaccine for Cutaneous Melanoma

Who this might be right for
Cutaneous Melanoma, Stage IIICutaneous Melanoma, Stage IV
TuHURA Biosciences, Inc. 7
Testing effectiveness (Phase 2)Study completedNCT00412828
What this trial is testing

A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Unresectable Stage III or Stage IV Melanoma
CuraGen Corporation 117
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Early research (Phase 1)Study completedNCT01245556
What this trial is testing

Safety and Efficacy Study of BMS-908662 in Combination With Ipilimumab in Subjects With Advanced Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT04562129
What this trial is testing

IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVInoperable Disease
H. Lee Moffitt Cancer Center and Research Institute 18
Large-scale testing (Phase 3)Ended earlyNCT01013623
What this trial is testing

Stage IV Surgery Versus Best Medical Therapy

Who this might be right for
Stage IV Resectable Melanoma
Saint John's Cancer Institute 12
Next Page